Loading...
XSHG
600721
Market cap371mUSD
Jul 09, Last price  
6.55CNY
1D
-2.09%
1Q
-30.39%
Jan 2017
-64.71%
Name

Xinjiang Bai Hua Cun Co Ltd

Chart & Performance

D1W1MN
XSHG:600721 chart
P/E
61.91
P/S
6.50
EPS
0.11
Div Yield, %
Shrs. gr., 5y
-0.29%
Rev. gr., 5y
35.60%
Revenues
388m
+0.48%
52,846,48837,562,32039,089,94163,649,936696,564,2511,209,836,8881,118,869,8191,235,484,8041,108,870,132808,805,221744,574,204419,502,542419,189,442262,017,71784,530,413281,353,040349,884,561369,277,391385,755,766387,600,170
Net income
41m
-1.91%
1,283,0285,630,5316,703,01417,060,94741,038,76575,539,09420,465,3612,089,000-233,625,366-405,982,726139,134,162-564,115,290-675,291,47634,384,707-319,765,47159,827,140-34,764,74112,972,34441,479,04540,687,937
CFO
33m
-58.97%
6,480,98411,085,98712,251,0320339,112,920559,640,574342,002,9396,631,614202,160,848423,580,9520080,553,717-6,795,414-23,281,21334,721,68353,177,02762,079,86580,288,55632,944,117
Dividend
May 22, 19970.0783 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd conducts its operations across a diverse range of business sectors. Its core activities encompass pharmaceutical research and development, clinical studies, and the field of biomedicine, alongside investments in commercial properties and various other ventures. This enterprise, officially renamed Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd in July 2021, previously operated as Xinjiang Baihuacun Co., Ltd. Established in 1959, the company maintains its headquarters in Urumqi, China.
IPO date
Jun 26, 1996
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT